Stocks and Investing
Stocks and Investing
Mon, March 20, 2017
[ 12:00 AM ] - United States, WOPRAI
Fri, March 17, 2017
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 01:46 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Liisa Bayko Upgraded (VRTX) to Buy on, Mar 17th, 2017
Liisa Bayko of JMP Securities, Upgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Buy on, Mar 17th, 2017.
Liisa has made no other calls on VRTX in the last 4 months.
There are 3 other peers that have a rating on VRTX. Out of the 3 peers that are also analyzing VRTX, all agree with Liisa's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Hartaj Singh of "Oppenheimer" Initiated at Hold on, Thursday, December 15th, 2016
- Geoff Meacham of "Barclays" Downgraded from Buy to Hold on, Tuesday, November 29th, 2016
- Debjit Chattopadhyay of "Janney Montgomery Scott" Initiated at Hold and Held Target at $98 on, Friday, November 18th, 2016
Contributing Sources